Valiant Laboratories Ltd. Statistics
Want to see IN:VALIANTLAB full AI Analyst Report?
Valiant Laboratories Ltd. (VALIANTLAB) Stock Statistics & Valuation Metrics
Total Valuation
Valiant Laboratories Ltd. has a market cap or net worth of INR 5.95B. The enterprise value is INR 6.88B.
- Market Cap
- INR 5.95B
- Enterprise Value
- INR 6.88B
Share Statistics
Valiant Laboratories Ltd. has 54,312,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 54,312,500
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Valiant Laboratories Ltd.’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.41%.
- Return on Equity (ROE)
- -0.01
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -0.41%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 28.27M
- Profits Per Employee
- -389.04K
- Employee Count
- 84
- Asset Turnover
- 0.51
- Inventory Turnover
- 4.63
Valuation Ratios
The current PE Ratio of Valiant Laboratories Ltd. is 35.87. Valiant Laboratories Ltd.’s PEG ratio is -0.05.
- PE Ratio
- 35.87
- PS Ratio
- 1.54
- PB Ratio
- 1.75
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Valiant Laboratories Ltd. had revenue of 2.37B and earned -32.68M in profits. Earnings per share was -0.51.
- Revenue
- 2.37B
- Gross Profit
- 272.66M
- Operating Income
- 3.50M
- Pretax Income
- 7.68M
- Net Income
- -32.68M
- EBITDA
- 87.11M
- Earnings Per Share (EPS)
- -0.51
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Valiant Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 2.79%
Stock Price Statistics
- Beta
- 0.29
- 52-Week Price Change
- 34.11%
- 50-Day Moving Average
- 122.13
- 200-Day Moving Average
- 81.55
- Relative Strength Index (RSI)
- 32.55
- Average Volume (3m)
- 25.44K
Important Dates
Valiant Laboratories Ltd. upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 02, 2026
- Next Earnings Date
- Feb 14, 2027
- Ex-Dividend Date
- ―
Financial Position
Valiant Laboratories Ltd. as a current ratio of 1.91, with Debt / Equity ratio of 14.86%
- Current Ratio
- 1.91
- Quick Ratio
- 1.53
- Debt to Market Cap
- 0.14
- Net Debt to EBITDA
- 4.50
- Interest Coverage Ratio
- 0.18
Taxes
In the past 12 months, Valiant Laboratories Ltd. has paid 40.36M in taxes.
- Income Tax
- 40.36M
- Effective Tax Rate
- 5.25
Enterprise Valuation
Valiant Laboratories Ltd. EV to EBITDA ratio is 16.06, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.64
- EV to EBITDA
- 16.06
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Valiant Laboratories Ltd. has INR 369.49M in cash and marketable securities with INR 377.84M in debt, giving a net cash position of -INR 8.35M billion.
- Cash & Marketable Securities
- INR 369.49M
- Total Debt
- INR 377.84M
- Net Cash
- -INR 8.35M
- Net Cash Per Share
- -INR 0.15
- Tangible Book Value Per Share
- INR 61.18
Margins
Gross margin is 19.44%, with operating margin of 7.13%, and net profit margin of 4.31%.
- Gross Margin
- 19.44%
- Operating Margin
- 7.13%
- Pretax Margin
- 6.62%
- Net Profit Margin
- 4.31%
- EBITDA Margin
- 10.23%
- EBIT Margin
- 7.18%
Analyst Forecast
The average price target for Valiant Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 102.37%
- EPS Growth Forecast
- 176.45%
Scores
- Smart Score
- ―
- AI Score
- 50
